Article ID Journal Published Year Pages File Type
3192313 Annals of Allergy, Asthma & Immunology 2010 10 Pages PDF
Abstract
In patients with PAR and RDS, mometasone furoate NS use improved nasal symptoms, sleepiness, and impairment in daily activities. Correlated reduced nasal symptoms and improved performance suggest that improving AR symptoms with mometasone furoate NS administration can benefit sleep and daytime functioning.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Authors
, , , , ,